Open AccessRisk of acute kidney injury in critically ill surgical patients with presumed pneumonia is not impacted by choice of methicillin-resistant staphylococcus aureus therapy
Author(s) -
Kelsey Billups,
Erica E Reed,
Gary Phillips,
Kurt Stevenson,
Steven M. Steinberg,
Claire V. Murphy
Publication year - 2018
Publication title -
international journal of critical illness and injury science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.274
H-Index - 12
eISSN - 2231-5004
pISSN - 2229-5151
DOI - 10.4103/ijciis.ijciis_46_17
Subject(s) - medicine , linezolid , rifle , vancomycin , acute kidney injury , pneumonia , renal function , methicillin resistant staphylococcus aureus , intensive care medicine , surgery , staphylococcus aureus , history , archaeology , biology , bacteria , genetics
Vancomycin and linezolid are standard treatment options for nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. While acute kidney injury (AKI) is commonly attributed to vancomycin, existing data has not definitely confirmed vancomycin as an independent risk factor for AKI.